Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory

American Journal of Neuroradiology

Volumn 34, Issue 11, 2013, Pages 2119-2124

  Eilaghi, A ^a,b   Kassner, A ^c,d   Sitartchouk, I ^c   Francis, P L ^a   Jakubovic, R ^a   Feinstein, A ^a   Aviv, Richard I ^a,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECK DEPRESSION INVENTORY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; INFORMATION PROCESSING SPEED; LEARNING; MALE; MEMBRANE PERMEABILITY; MENTAL FUNCTION; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORIENTATION; WHITE MATTER; WORKING MEMORY;

COGNITION; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NERVE FIBERS, MYELINATED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84888152974     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3539     Document Type: Article

References (47)

1. Barnett MH, Sutton I. The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 2006;19:242-47 (Pubitemid 43804677)
2. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-51
3. Filippi M, Rocca MA, Benedict RH, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010;75:2121-28
4. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17
5. Soon D, Tozer DJ, Altmann DR, et al. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 2007;13:884-94 (Pubitemid 351540860)
6. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128(Part 11):2705-12 (Pubitemid 41552953)
7. Sperling RA, Guttmann CR, Hohol MJ, et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001;58:115-21 (Pubitemid 32053215)
8. van Buchem MA, Grossman RI, Armstrong C, et al. Correlation of volumetric magnetization transfer imaging with clinical data in MS. Neurology 1998;50:1609-17 (Pubitemid 28283225)
9. Benedict RH, Bruce J, Dwyer MG, et al. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler 2007;13:722-30 (Pubitemid 47074094)
10. Mainero C, Caramia F, Pozzilli C, et al. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 2004;21:858-67 (Pubitemid 38314947)
11. Penny S, Khaleeli Z, Cipolotti L, et al. Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology 2010;74:545-52
12. Inglese M, Adhya S, Johnson G, et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008;28:164-71
13. Zivadinov R, Sepcic J. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]. Lijec Vjesn 2006;128:295-308
14. Filippi M, Agosta F. Imaging biomarkers in multiple sclerosis. J Magn Reson Imaging 2010;31:770-88
15. Zeis T, Graumann U, Reynolds R, et al. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008;131(Part 1):288-303
16. Graumann U, Reynolds R, Steck AJ, et al. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol 2003;13:554-73 (Pubitemid 37420699)
17. Lassmann H. Multiple sclerosis: is there neurodegeneration independent from inflammation? J Neurol Sci 2007;259:3-6 (Pubitemid 47031195)
18. Lanz M, Hahn HK, Hildebrandt H. Brain atrophy and cognitive impairment in multiple sclerosis: a review. J Neurol 2007;254(Suppl 2):II43-48
19. Jackson A, Kassner A, Zhu XP, et al. Reproducibility of T2*blood volume and vascular tortuosity maps in cerebral gliomas. J Magn Reson Imaging 2001;14:510-16 (Pubitemid 33029536)
20. Jackson A, Kassner A, Annesley-Williams D, et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. AJNR Am J Neuroradiol 2002;23:7-14 (Pubitemid 34098254)
21. Kassner A, Zhu XP, Li KL, et al. Neoangiogenesis in association with Moyamoya syndrome shown by estimation of relative recirculation based on dynamic contrast-enhanced MR images. AJNR Am J Neuroradiol 2003;24:810-18 (Pubitemid 36617406)
22. Wu S, Thornhill RE, Chen S, et al. Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol 2009;44:662-68
23. Dade LA, Gao FQ, Kovacevic N, et al. Semiautomatic brain region extraction: a method of parcellating brain regions from structural magnetic resonance images. Neuroimage 2004;22:1492-502 (Pubitemid 38962638)
24. Robb RA, Hanson DP, Karwoski RA, et al. Analyze: a comprehensive, operator-interactive software package for multidimensional medical image display and analysis. Comput Med Imaging Graph 1989;13:433-54 (Pubitemid 20019803)
25. Aviv RI, Francis PL, Tenenbein R, et al. Decreased frontal lobe gray matter perfusion in cognitively impaired patients with secondary-progressive multiple sclerosis detected by the bookend technique. AJNR Am J Neuroradiol 2012;33:1779-85
26. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65 (Pubitemid 20248610)
27. Kassner A, Annesley DJ, Zhu XP, et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103-13 (Pubitemid 30080962)
28. Benedict RH, Fischer JS, Archibald CJ, et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002;16:381-97 (Pubitemid 36390381)
29. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120(Part 6):1085-96 (Pubitemid 27259557)
30. Heaton RK, Nelson LM, Thompson DS, et al. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 1985;53:103-10 (Pubitemid 15096165)
31. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132(Part 5):1175-89
32. Benedict RH, Cookfair D, Gavett R, et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006;12:549-58 (Pubitemid 44070305)
33. Drake AS, Weinstock-Guttman B, Morrow SA, et al. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test. Mult Scler 2010;16:228-37
34. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226-30 (Pubitemid 38197556)
35. Christodoulou C, Krupp LB, Liang Z, et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003;60:1793-98 (Pubitemid 36737076)
36. Lockwood AH, Linn RT, Szymanski H, et al. Mapping the neural systems that mediate the Paced Auditory Serial Addition Task (PASAT). J Int Neuropsychol Soc 2004;10:26-34 (Pubitemid 38128459)
37. Dineen RA, Vilisaar J, Hlinka J, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009;132(Part 1):239-49
38. Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis I: inflammation and lesions. Front Biosci 2004;9:665-83 (Pubitemid 39043742)
39. Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 2005;15(4 Suppl):10S-21S. (Pubitemid 43010528)
40. Filippi M, Wolinsky JS, Sormani MP, et al. Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis. Neurology 2001;56:422-23 (Pubitemid 32144167)
41. Silver NC, Tofts PS, Symms MR, et al. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study. Mult Scler 2001;7:75-82 (Pubitemid 32514520)
42. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol 2008;43:141-44
43. Cheng HL. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging 2008;28:736-43
44. Ingrisch M, Sourbron S, Morhard D, et al. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Invest Radiol 2012;47:252-58
45. O'Sullivan M, Morris RG, Huckstep B, et al. Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 2004;75:441-47 (Pubitemid 38338776)
46. Parkinson RB, Hopkins RO, Cleavinger HB, et al. White matter hyperintensities and neuropsychological outcome following carbon monoxide poisoning. Neurology 2002;58:1525-32 (Pubitemid 34552961)
47. Kennedy MR, Wozniak JR, Muetzel RL, et al. White matter and neurocognitive changes in adults with chronic traumatic brain injury. J Int Neuropsychol Soc 2009;15:130-36